Zhi Hong
View Zhi Hong's Email
View Zhi Hong's Email & Phone
Real-Time AI Research
0 search queries left
FlashIntel GPT
Hello! I'm FlashIntel GPT, your personal AI search assistant. Feel free to ask me anything about Zhi Hong, and I'll do my best to assist you.

Tell me more about Zhi Hong?

FlashIntel GPT

Zhi Hong is a highly experienced professional with 16.8 years of work experience in the pharmaceutical industry. He has a strong background in business strategy, drug development, clinical development, and drug discovery. Currently, he is the Co-founder, President, and Chief Executive Officer at Brii Biosciences. Prior to this, he held senior positions at GlaxoSmithKline's Infectious Diseases Therapy Area Unit and ViiV Healthcare's. He is known for his expertise in HIV and infectious diseases medicine discovery and development. Dr. Hong is also a public health advocate and has successfully built numerous public-private partnerships with the U.S./E.U. governments.
For inquiries about Phone Number and Email, please click here Unlock Contact

Research Details
Skills & Insights

Emails and Phone Numbers

View Emails and Phone Numbers
10 free lookups per month


Zhi Hong, Ph.D., is Co-founder, President, and Chief Executive Officer. Prior to starting Brii Bio, Dr. Hong was Senior Vice President and Head of GlaxoSmithKline's (GSK) Infectious Diseases Therapy Area Unit. He was widely credited as the key architect of GSK's comeback and success in HIV &a; Infectious Diseases medicine discovery and development. Under his leadership, ViiV Healthcare’s (a joint venture between GSK, Pfizer, and Shionogi) HIV business was revitalized with the approval of Tivicay &a; Triumeq. Dr. Hong was the champion of GSK's effort in long-acting HIV treatment &a; prevention therapies. He also built GSK's efforts to cure HBV and HIV infections. GSK now has one of the most innovative pipelines against infectious diseases. Dr. Hong is a public health advocate who has helped establish multiple public-private partnerships with the U.S./E.U. governments (DTRA, BARDA, NIH &a; IMI) and philanthropic organizations (Gates Foundation &a; Wellcome Trust). In the last two years, he helped to create GSK's Institute for Infectious Diseases and Public Health in Beijing, China. Dr. Hong started Ardea Biosciences (later acquired by AstraZeneca). He also held leadership positions at Valeant Pharmaceuticals and Schering-Plough Research Institute (now Merck). Dr. Hong has more than 25 years of experience in drug discovery and development and has brought more than 30 compounds into development, including many that have been approved and launched. He has served as a board member of Anacor Pharmaceuticals (acquired by Pfizer) and ViiV Healthcare, and also chaired the board of Qura Therapeutics.

...See More

Work Experience

110 N Corcoran St, Durham, North Carolina, 27701, US
Show More

Zhi Hong's Professional Milestones

  • SVP (2007-01-01~2018-01-01): Secured successful ventures and established a strong market presence on a global scale.
  • Co-Founder | President | Chief Executive Officer (2018-05-01~): Guided and empowered the company to reach global dominance, revolutionizing the industry.
Show More